TAIPEI and SAN DIEGO, Aug. 12, 2026 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492) today announced a significant research advance involving its investigational drug Pidnarulex (CX-5461). A multinational research team comprising investigators from Poland, Slovakia, France and Senhwa…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
